39269-74-4 Usage
Chemical structure
1-benzyl-2-methyl-1H-imidazole-5-carbaldehyde is a derivative of imidazole with a benzyl group attached to the nitrogen atom and an aldehyde functional group.
Applications
It is commonly used in organic synthesis and medicinal chemistry.
Building block
The presence of the aldehyde functional group makes it a versatile building block for the synthesis of various pharmaceuticals and biologically active compounds.
Antibacterial and antifungal properties
It is known for its potential antibacterial and antifungal properties.
Drug development
It has been studied for its potential use in the development of new drugs.
Reagent
It has shown potential as a reagent for the synthesis of heterocyclic compounds.
Intermediate
It is a valuable intermediate in the production of various pharmaceuticals and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 39269-74-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,2,6 and 9 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 39269-74:
(7*3)+(6*9)+(5*2)+(4*6)+(3*9)+(2*7)+(1*4)=154
154 % 10 = 4
So 39269-74-4 is a valid CAS Registry Number.
39269-74-4Relevant articles and documents
METHOD FOR PREPARATION OF BENZIMIDAZOLE DERIVATIVES
-
Paragraph 172; 173; 174, (2015/02/02)
The present invention provides a method for preparing a compound with a benzimidazole structure with an excellent yield using a low-cost starting material, not requiring an additional separation process, or not using a dangerous reagent during the manufacturing process. Furthermore, the present invention also provides an intermediate and a final product produced by the preparing method.
Imidazolo-5-YL-2anilino-pyrimidines as agents for the inhibition of the cell proliffration
-
Page/Page column 32, (2010/02/05)
Compounds of the formula (I): wherein R1, R2, R3, R4, R5, R6, p, q, and n are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.